Corticosteroid Conversion and Clinical Considerations
Corticosteroid Potency Ratios
- Dexamethasone is approximately 5 times more potent than prednisone, with an equivalent dose of 4 mg for prednisone 20 mg 1, 2
- Dexamethasone is 25 times more potent than hydrocortisone (cortisol) 1
- Prednisone is 4 times more potent than hydrocortisone 1
- Methylprednisolone is 5 times more potent than hydrocortisone 1
- Based on these ratios, a 5:1 ratio (prednisone:dexamethasone) is commonly used in clinical practice 2
Conversion Table for Common Corticosteroids
- Prednisone 5 mg is equivalent to Dexamethasone 1 mg 1
- Prednisone 20 mg is equivalent to Dexamethasone 4 mg 1, 2
- Prednisone 60 mg is equivalent to Dexamethasone 10 mg 1
- Prednisone 60 mg is equivalent to Methylprednisolone 48 mg 1
Clinical Considerations
- Single daily dosing is recommended for dexamethasone rather than divided doses 3
- When switching between corticosteroids, consider the clinical context and indication for therapy 4
- For perioperative use in patients with inflammatory bowel disease, hydrocortisone 20 mg IV is equivalent to oral prednisolone 5 mg 4
- Patients taking prednisone ≥20 mg daily (or equivalent) may have a blunted response to certain vaccinations 5, 6
- For non-emergency surgery, corticosteroids should be minimized when possible to reduce postoperative complications 4
- When using high-dose corticosteroids, be aware of potential adverse effects including hyperglycemia, sleep disturbances, and increased infection risk 2
Prednisone to Methylprednisolone Conversion Guidelines
Clinical Application Examples
- For immune checkpoint inhibitor toxicities, a dose of prednisone 1 mg/kg/day (or equivalent dose of methylprednisolone) is recommended, using the 1.25:1 conversion ratio, as suggested by the Society for Immunotherapy of Cancer 7, 8, 9, 10
- For polymyalgia rheumatica, initial doses of 12.5-25 mg prednisone equivalent daily can be converted using the standard ratio, according to the European League Against Rheumatism 11
- For lupus nephritis, pulse methylprednisolone 500-2500 mg followed by oral prednisone uses the conversion framework, as recommended by the European League Against Rheumatism 12
Important Medication Safety
- Do not confuse methylprednisolone with methylprednisone, as they are different compounds, as noted by the International Society of Nephrology 13
Corticosteroid Conversion Guidelines
Introduction to Corticosteroid Conversion
- Dexamethasone is approximately 5 times more potent than prednisolone/prednisone, according to the American Academy of Otolaryngology-Head and Neck Surgery 14
Clinical Context and Dosing Strategy
- In patients who are unable to take oral medications, such as those with severe nausea or vomiting, conversion to injectable dexamethasone may be appropriate, as recommended by the Gut journal 15
- In the perioperative period where IV access is established and oral intake is restricted, conversion to injectable dexamethasone may be necessary, as suggested by the Gut journal 16, 15
- The American Gastroenterological Association recommends maintaining equivalent dosing when converting from prednisolone to dexamethasone in the perioperative period, with prednisolone 30mg oral being equivalent to dexamethasone 6mg IV 15
Important Considerations and Monitoring
- The use of dexamethasone may increase the risk of hyperglycemia, particularly at higher doses, as noted by the Gut journal 16
- Patients on corticosteroids, including dexamethasone, are at increased risk of infection and should be monitored accordingly, as recommended by the Gut journal 16, 15
- The British Association of Dermatologists suggests considering proton pump inhibitor use in patients on corticosteroids who are not eating to prevent gastrointestinal complications 17
- The risk of venous thromboembolism should be considered in patients on corticosteroids, and prophylaxis may be necessary if additional risk factors are present, as recommended by the Gut journal 15
Hydrocortisone to Prednisolone Conversion Guidelines
Clinical Application by Scenario
- When transitioning patients from perioperative IV hydrocortisone coverage back to oral maintenance, if the patient was receiving hydrocortisone 200 mg/24 hours IV, transition to oral prednisolone at approximately 50 mg daily initially, then taper 18, 19, 20
- Resume oral glucocorticoid at double the pre-surgical dose for 48 hours if recovery is uncomplicated, then return to baseline maintenance 18, 19, 20
- For major surgery, continue doubled oral doses for up to one week if complications arise 18, 19, 20
Acute Severe Conditions
- When converting from IV hydrocortisone to oral prednisolone in acute illness, hydrocortisone 100 mg IV four times daily (400 mg/day) is equivalent to prednisolone 60-80 mg daily 21
- Once the patient tolerates oral intake and shows clinical improvement, switch directly to oral prednisolone at equivalent dosing 21
Corticosteroid Potency and Clinical Guidance
Clinical Equivalence and Dosing Conversions
- The British Journal of Dermatology recommends prednisone 0.5 mg/kg daily as equivalent to methylprednisolone 0.4 mg/kg daily for bullous pemphigoid 22
- The Annals of the Rheumatic Diseases suggests prednisone 12.5-25 mg daily is equivalent to methylprednisolone 10-20 mg daily for polymyalgia rheumatica 23
- The Annals of the Rheumatic Diseases also recommends considering methylprednisolone for patients with high inflammatory markers, such as elevated RF or RAPA in rheumatoid conditions 24
Bone Protection Measures
- The British Journal of Dermatology advises that both prednisone and methylprednisolone require identical bone protection measures, including calcium and vitamin D supplementation with bisphosphonates for patients expected to take prednisone ≥7.5 mg daily (or methylprednisolone ≥6 mg daily) for ≥3 months 22
Conversion from Prednisone to Methylprednisolone in Adults
Clinical Application by Route
- When converting from oral prednisone to IV methylprednisolone, use the same 1.25:1 ratio, as bioavailability of both oral formulations is excellent, and for grade 3-4 toxicities requiring hospitalization, administer IV methylprednisolone 1-2 mg/kg, which equals prednisone 1.25-2.5 mg/kg, according to the American Society of Clinical Oncology 25, 26
- When appropriate, convert back to oral steroids using the same ratio and taper over at least 4 weeks, as recommended by the American Society of Clinical Oncology 25, 26
Corticosteroid Dose Equivalence
Standard Conversion Ratios and Clinical Applications
- The British Society of Gastroenterology recommends that methylprednisolone 60 mg daily is equivalent to hydrocortisone 100 mg every 6 hours (400 mg/day total) 27
- For septic shock management, the recommended dose is hydrocortisone <400 mg/day (typically 100 mg every 6 hours = 400 mg/day), which equates to methylprednisolone 60-80 mg daily 28, 29, 30, 27
- Hydrocortisone 300 mg/day is equivalent to methylprednisolone 60 mg/day 31
- Prednisolone 75 mg/day is equivalent to hydrocortisone 300 mg/day 31
Important Clinical Considerations
- Methylprednisolone has minimal mineralocorticoid activity at therapeutic doses, whereas hydrocortisone has substantial mineralocorticoid effects, causing more hypokalaemia and sodium retention 27
- When converting from hydrocortisone to methylprednisolone, it is recommended to monitor potassium levels as supplementation needs may decrease 27
- For septic shock, it is recommended to use hydrocortisone <400 mg/day for ≥3 days at full dose rather than high-dose short courses 28, 29, 30
Glucocorticoid Equivalent Dosing and Clinical Conversion Guidelines
Standard Equivalent Doses
- The anti‑inflammatory potency of commonly used glucocorticoids is equivalent as follows: hydrocortisone 20 mg = prednisone/prednisolone 5 mg = methylprednisolone 4 mg = triamcinolone 4 mg = dexamethasone 0.75 mg = betamethasone 0.75 mg. 32
Conversion Table (oral or IV)
| Glucocorticoid | Equivalent Dose (anti‑inflammatory) |
|---|---|
| Hydrocortisone | 20 mg |
| Prednisone / Prednisolone | 5 mg |
| Methylprednisolone | 4 mg |
| Triamcinolone | 4 mg |
| Dexamethasone | 0.75 mg |
| Betamethasone | 0.75 mg |
All doses are based on oral or intravenous administration. 32
Potency Ratios for Clinical Conversion
- Prednisone/Prednisolone are 4 × more potent than hydrocortisone (divide hydrocortisone dose by 4). 32
- Methylprednisolone is 5 × more potent than hydrocortisone (divide hydrocortisone dose by 5). 32
- Dexamethasone is 25 × more potent than hydrocortisone (divide hydrocortisone dose by 25). 32
Perioperative and Stress‑Dose Conversions
- For surgical stress coverage, prednisolone 5 mg oral is equivalent to hydrocortisone 20 mg IV and methylprednisolone 4 mg IV. 32
- Dexamethasone 8 mg provides coverage comparable to hydrocortisone 200 mg over a 24‑hour period. 32
Mineralocorticoid Activity Considerations
- Dexamethasone and betamethasone have no mineralocorticoid activity and therefore are unsuitable as sole stress‑coverage agents in primary adrenal insufficiency. 32
- Hydrocortisone possesses substantial mineralocorticoid effects, whereas prednisone/prednisolone have roughly 1/25th the mineralocorticoid activity of hydrocortisone. 32
Administration Route Caveats
- The listed dose relationships are valid only for oral or intravenous administration; intramuscular or intra‑articular routes may markedly alter relative potency. 32
- All oral glucocorticoid formulations have excellent bioavailability and rapid absorption. 32
Pharmacokinetic Highlights
- Hydrocortisone has a plasma elimination half‑life of ≈ 90 minutes, which can be shortened by CYP3A4 inducers or hyperthyroidism and prolonged in critically ill patients. 32
- Dexamethasone is a long‑acting agent providing ≈ 24‑hour glucocorticoid coverage. 32
Special Populations & Adjustment Recommendations
- Patients on chronic glucocorticoid therapy for ≥ 4 weeks should receive stress‑dose coverage during physiological stress or surgery to prevent adrenal crisis. 32
- Traditional conversion ratios may require adjustment in obese individuals or those taking CYP3A4‑inducing medications, although high‑quality evidence for specific modifications is limited. 32
Substitution of Prednisone for Dexamethasone: Evidence‑Based Considerations
Clinical Situations Where Dexamethasone Should Not Be Replaced
In chemotherapy‑induced nausea and vomiting protocols, dexamethasone is the evidence‑based standard anti‑emetic; substituting prednisone is not recommended. 33, 34, 35
For adjunctive therapy in bacterial meningitis, dexamethasone (not prednisone) has been specifically studied and is recommended to improve outcomes. 36
Adverse‑Effect Profile Differences Relevant to Substitution
- Prednisone retains mineralocorticoid activity and is associated with fluid retention and peripheral edema, whereas dexamethasone lacks these effects. 36
Corticosteroid Dose Equivalence in Guideline Recommendations
Guideline‑Defined Equivalence Ratios
- The European Society of Cardiology states that prednisone 25 mg is dose‑equivalent to methylprednisolone 20 mg, preserving the 1.25 : 1 conversion ratio used in clinical practice. This equivalence is applied when selecting glucocorticoid therapy for cardiovascular patients. 37
Alternative Administration Regimens
- The EULAR/ACR collaborative guidelines report that intramuscular methylprednisolone 120 mg administered every 3 weeks was employed as an alternative to oral prednisone regimens in clinical trials for rheumatic conditions, demonstrating comparable efficacy in disease control. 38
High‑Dose Glucocorticoid Definitions (American College of Rheumatology)
Pulse Intravenous Therapy
- The American College of Rheumatology defines a high‑dose pulse glucocorticoid regimen as ≥10 mg/kg/day of methylprednisolone (or equivalent) for severe autoimmune flares. 39
High‑Dose Oral Therapy
- The American College of Rheumatology defines high‑dose oral glucocorticoid therapy as ≥2 mg/kg/day of prednisone (or equivalent). 39